Our health economics research focuses on evaluating healthcare costs, resource utilization, economic burden, and the value of prevention and treatment strategies across infectious diseases and other health conditions.
Health Economic & Burden
Health Economics
Health economics research is essential for understanding the financial impact of disease and healthcare interventions, helping inform efficient resource allocation, policy decisions, and strategies to improve population health.
Key Publications
- Griffiths EA, Vadlamudi NK. Cadth’s $50,000 cost-effectiveness threshold: fact or fiction? Value in Health 19 (7), A488-A489
- Griffiths EA, Macaulay R, Vadlamudi NK, Uddin J, Samuels ER. The Role of Noncomparative Evidence in Health Technology Assessment Decisions. Value Health. 2017 Dec;20(10):1245-1251. doi: 10.1016/j.jval.2017.06.015. Epub 2017 Sep 12. PMID: 29241883.
- Vadlamudi NK, Chen A, Marra F. Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis. Clin Infect Dis. 2019 Jun 18;69(1):34-49. doi: 10.1093/cid/ciy872. PMID: 30312379.
- Marra F, Zhang A, Gillman E, Bessai K, Parhar K, Vadlamudi NK. The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis. Int J Infect Dis. 2020 Oct;99:204-213. doi: 10.1016/j.ijid.2020.07.038. Epub 2020 Jul 29. PMID: 32735953.
- Vadlamudi NK, Patrick DM, Rose C, Sadatsafavi M, Hoang L, Marra F. A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada. Vaccine. 2022 Feb 11;40(7):1047-1053. doi: 10.1016/j.vaccine.2021.12.065. Epub 2022 Jan 7. PMID: 35012778.